{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:07Z","timestamp":1787071087634,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Oxaliplatin is a common drug used in the management of colorectal malignancies. Rare neurological side effects including amaurosis fugax, urinary retention, stroke, cranial nerve palsy, dysarthria, and dysphagia have been reported in the literature. Usually, such incidences are reported immediately after 1\n                    <jats:sup>st<\/jats:sup>\n                    dose of oxaliplatin infusion. We report a rare transient ischemic attack (TIA))-like side effects after 2\n                    <jats:sup>nd<\/jats:sup>\n                    dose of oxaliplatin infusion.\n                  <\/jats:p>","DOI":"10.4103\/jcrt.jcrt_788_24","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:02:11Z","timestamp":1728295331000},"page":"1599-1601","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Oxaliplatin-induced transient ischemic attack (TIA): A rare presentation"],"prefix":"10.4103","volume":"20","author":[{"given":"Vikas K.","family":"Jagtap","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiakmenlang","family":"Synmon","sequence":"additional","affiliation":[{"name":"Department of Neurology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiwakor","family":"Chyrmang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"R1-20241226","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","article-title":"Chemotherapy-induced neuropathy:A comprehensive survey","volume":"40","author":"Miltenburg","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R2-20241226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R3-20241226","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.seminoncol.2006.03.006","article-title":"Neurologic complications of cancer chemotherapy","volume":"33","author":"Sul","year":"2006","journal-title":"Semin Oncol"},{"key":"R4-20241226","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1054\/bjoc.2001.2024","article-title":"Nucleolar damage correlates with neurotoxicity induced by different platinum drugs","volume":"85","author":"McKeage","year":"2001","journal-title":"Br J Cancer"},{"key":"R5-20241226","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000521842","article-title":"Amaurosis fugax:A rare oxaliplatin-induced ocular toxicity - A report of three cases","volume":"15","author":"Tunio","year":"2022","journal-title":"Case Rep Oncol"},{"key":"R6-20241226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000380849","article-title":"Severe generalized weakness, paralysis, and aphasia following administration of irinotecan and oxaliplatin during FOLFIRINOX chemotherapy","volume":"8","author":"Chandar","year":"2015","journal-title":"Case Rep Oncol"},{"key":"R7-20241226","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1177\/10781552211004985","article-title":"Motor \u201cfreezing\u201dwith Oxaliplatin","volume":"27","author":"Patel","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"R8-20241226","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1078155213506477","article-title":"A curious case of oxaliplatin-induced neurotoxicity:Recurrent, self-limiting dysarthria","volume":"20","author":"Joseph","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"R9-20241226","doi-asserted-by":"crossref","first-page":"23426","DOI":"10.18632\/oncotarget.25193","article-title":"Oxaliplatin-induced blood brain barrier loosening:A new point of view on chemotherapy-induced neurotoxicity","volume":"9","author":"Branca","year":"2018","journal-title":"Oncotarget"},{"key":"R10-20241226","doi-asserted-by":"crossref","first-page":"bcr2017221571","DOI":"10.1136\/bcr-2017-221571","article-title":"Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)","volume":"2017","author":"Janjua","year":"2017","journal-title":"BMJ Case Rep"},{"key":"R11-20241226","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/brain\/awp219","article-title":"Oxaliplatin-induced neurotoxicity:Changes in axonal excitability precede development of neuropathy","volume":"132","author":"Park","year":"2009","journal-title":"Brain"},{"key":"R12-20241226","first-page":"10781552231181525","article-title":"Unusual stroke-like symptoms with Oxaliplatin use","author":"Soliman","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"R13-20241226","doi-asserted-by":"crossref","first-page":"201593","DOI":"10.1155\/2011\/201593","article-title":"Oxaliplatin-induced neuropathy in colorectal cancer","volume":"2011","author":"Weickhardt","year":"2011","journal-title":"J Oncol"},{"key":"R14-20241226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1200\/JCO.2010.31.5911","article-title":"Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer:NCCTG N04C7","volume":"29","author":"Grothey","year":"2011","journal-title":"J Clin Oncol"},{"key":"R15-20241226","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ctrv.2008.01.003","article-title":"A review on oxaliplatin-induced peripheral nerve damage","volume":"34","author":"Argyriou","year":"2008","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_788_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:17Z","timestamp":1787067677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_788_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_788_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}